Abstract:The absence of a correlation between erythropoietin and birth weight or length and the negative correlations between alpha-fetoprotein and these anthropometric parameters suggest that the intra-uterine growth retardation caused by maternal smoking is not due to tissue hypoxia, but that both growth retardation and elevated alpha-fetoprotein result from the direct or indirect toxic effect of a factor(s) present in tobacco smoke.
“…This result could suggest that increased t-AFP levels may be present in any situation in which fetal growth is seriously affected regardless of the cause of the condition. Along this line, Beratis et al [10] found that the increased cord serum AFP levels in newborns with IUGR associated with maternal smoking were not associated to fetal hypoxia (as there was no correlation between erythropoietin levels and birth weight), suggesting that elevations of cord serum AFP were associated to the direct or indirect toxic effect of a factor(s) present in tobacco smoke causing growth retardation. However, we also found that elevations of maternal serum t-AFP levels are especially marked in cases of fetuses with fetal chronic hypoxia suggested by the presence of hemodynamic redistribution.…”
Section: Discussionmentioning
confidence: 87%
“…However, this hypothesis can hardly explain two facts: (1) The inverse correlation between fetal (umbilical cord) AFP levels and birth weight [10][11][12] ; (2) MSAFP increases several weeks before both IUGR and any kind of placental lesions are manifest even though it has been speculated that these placental pathological changes can have their origin in the second trimester, although they are not evident until later in pregnancy [13] . In addition, in situations in which there is a clear placental abnormality that may lead to MSAFP elevations such as placental separation, stratified analyses have demonstrated that elevations of MSAFP and early gestation bleeding are independent predictors of low birth weight infants [14] .…”
Objective: To evaluate maternal serum transformed α-fetoprotein (t-AFP) levels in women with intrauterine growth retardation (IUGR). Methods: 60 pregnant women in two groups were studied: 30 with IUGR and 30 healthy pregnant women as a control group. t-AFP concentrations were determined by ELISA assay. Results: Maternal serum t-AFP levels were higher in women with IUGR than in the control group: 15.39 (10.81–24.01) ng/ml vs. 8.66 (6.22–13.45) ng/ml (p = 0.003). t-AFP levels were even higher in those with fetal hemodynamic redistribution 21.08 (16.02–40.85) ng/ml than in those without 12.15 (10.48–17.45) ng/ml (p = 0.03). Conclusions: Maternal serum t-AFP is increased in women with IUGR and this elevation is marked in those with fetal hemodynamic redistribution.
“…This result could suggest that increased t-AFP levels may be present in any situation in which fetal growth is seriously affected regardless of the cause of the condition. Along this line, Beratis et al [10] found that the increased cord serum AFP levels in newborns with IUGR associated with maternal smoking were not associated to fetal hypoxia (as there was no correlation between erythropoietin levels and birth weight), suggesting that elevations of cord serum AFP were associated to the direct or indirect toxic effect of a factor(s) present in tobacco smoke causing growth retardation. However, we also found that elevations of maternal serum t-AFP levels are especially marked in cases of fetuses with fetal chronic hypoxia suggested by the presence of hemodynamic redistribution.…”
Section: Discussionmentioning
confidence: 87%
“…However, this hypothesis can hardly explain two facts: (1) The inverse correlation between fetal (umbilical cord) AFP levels and birth weight [10][11][12] ; (2) MSAFP increases several weeks before both IUGR and any kind of placental lesions are manifest even though it has been speculated that these placental pathological changes can have their origin in the second trimester, although they are not evident until later in pregnancy [13] . In addition, in situations in which there is a clear placental abnormality that may lead to MSAFP elevations such as placental separation, stratified analyses have demonstrated that elevations of MSAFP and early gestation bleeding are independent predictors of low birth weight infants [14] .…”
Objective: To evaluate maternal serum transformed α-fetoprotein (t-AFP) levels in women with intrauterine growth retardation (IUGR). Methods: 60 pregnant women in two groups were studied: 30 with IUGR and 30 healthy pregnant women as a control group. t-AFP concentrations were determined by ELISA assay. Results: Maternal serum t-AFP levels were higher in women with IUGR than in the control group: 15.39 (10.81–24.01) ng/ml vs. 8.66 (6.22–13.45) ng/ml (p = 0.003). t-AFP levels were even higher in those with fetal hemodynamic redistribution 21.08 (16.02–40.85) ng/ml than in those without 12.15 (10.48–17.45) ng/ml (p = 0.03). Conclusions: Maternal serum t-AFP is increased in women with IUGR and this elevation is marked in those with fetal hemodynamic redistribution.
“…Intrauterine exposure to tobacco smoke causes several endocrine abnormalities in neonates [3,4,16,21]. Chronic fetal hypoxia, as indicated by increased erythropoietin concentrations [3,21] and reduced concentrations of leptin [16,22], could cause intrauterine growth retardation.…”
Length exhibits the most persistent growth delay of the parameters studied, but catch-up growth occurs after the second year of life, and thus, intrauterine exposure to tobacco smoke seems to have no permanent effect on children's growth.
“…The serum level of AFP, as a tumor marker of teratoma, was as high as 61 ± 44.8 μg/mL [5] or 57.7 ± 37.2 ng/mL [6] in newborns. A regression analysis of serum AFP levels in healthy infants showed that the levels regress according the equation of log Y = 7.397−2.622 · log (X + 10), where X = age in days and Y = AFP level in nanogram per milliliter, and descend to reference range (b20 ng/mL) at the age of 6 to 7 months [7].…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.